Jharkhand & Bihar Local News

Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant. The…
Read More...

The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe. Studies showed the drug called Paxlovid reduces hospitalisation and death in…
Read More...

कोरोना महामारी के खिलाफ जंग में 'संजीवनी' साबित हो चुके कोविशील्ड और कोवैक्सीन को लेकर अच्छी खबर है। ड्रग कंट्रोलर जनरल ऑफ इंडिया (डीसीजीआई) ने कोविशील्ड और कोवैक्सिन के लिए सशर्त बाजार की मंजूरी दे दी है। लेकिन वैक्सीन लगाने के लिए…
Read More...

Last year in December, Prime Minister Narendra Modi announced that booster shots will be available for frontline workers and senior citizens aged above 60 from January 10, 2022. This came after India saw rising cases of coronavirus…
Read More...

India reported 2,86,384 new Covid-19 cases and 573 deaths in the last 24 hours, showed the Union health ministry bulletin on Thursday morning. The country's positivity rate shot up from 16.16 per cent to 19.59 per cent. The weekly…
Read More...

Some posts on social media talked about one such infection named ‘flurona’ in Israel, which the users said is a double infection of Covid-19 and influenza. But healthcare experts have now dismissed this, saying it’s not a different thing.…
Read More...

Individuals infected with Omicron have a significant immune response which could neutralize not only Omicron but also other variants of concern, including the most prevalent Delta variant, an Indian Council of Medical Research (ICMR) study…
Read More...

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the omicron variant of the coronavirus. The trials will involve a total of 600 adults — half…
Read More...

The Omicron variant of Covid-19 is highly contagious and transmissible and now, according to a new study, the Omicron variant can survive up to eight days on plastic and 21 hours on the skin - a much longer time than other variants of…
Read More...

German biotechnology company BioNTech and US company Pfizer have started clinical trials of an Omicron-based Covid-19 vaccine candidate in healthy adults from 18 through 55 years of age, the companies have said. The trials would evaluate…
Read More...